Sports Prevents Breast Cancer. Part 2 of 2

Sports Prevents Breast Cancer – Part 2 of 2

No level of exercise affected the women’s endanger for estrogen receptor-positive breast cancer, according to the study findings, which were presented Wednesday at the San Antonio Breast Cancer Symposium. “These findings are very encouraging. Knowing that exercise may cover against breast cancers that disproportionately strike black women is of great public health importance,” Lucile Adams-Campbell, a professor of oncology and associate director of minority health and health disparities experiment with at the Georgetown Lombardi Comprehensive Cancer Center in Washington, DC, said in the news release.


So “We all want to do what we can to reduce our risk of disease and improve our health,” Adams-Campbell said. “Along with other illustrious benefits, we now show that exercise can possibly stave off development of potentially lethal breast cancer in black women”. Although the study found an association between regular vigorous exercise and lower risk of an unfriendly form of breast cancer in black women, it did not prove a cause-and-effect relationship read full article. In addition, the data and conclusions of research presented at medical meetings should be viewed as preliminary until published in a peer-reviewed journal.

Parts: 1 2


Sports Prevents Breast Cancer. Part 1 of 2

Sports Prevents Breast Cancer – Part 1 of 2

Sports Prevents Breast Cancer. Vigorous irritate on a regular basis might help protect black women against an aggressive form of breast cancer, researchers have found in Dec 2013. The altered study included nearly 45000 black women, aged 30 and older, who were followed for nearly 20 years. Those who engaged in vigorous exercise for a lifetime average of three or more hours a week were 47 percent less fitting to develop so-called estrogen receptor-negative breast cancer compared with those who exercised an average of one hour per week, the investigators found.

This type of knocker cancer, which includes HER2-positive and triple-negative tumors, is linked to both higher incidence and death risk in black women, compared to white women. These estrogen receptor-negative tumors do not rejoin to the types of hormone therapies used to treat tumors that have the estrogen receptor, the researchers said in a Georgetown University Medical Center news release.

Parts: 1 2

Years Of Attempts To Quit Smoking. Part 3 of 3

Years Of Attempts To Quit Smoking – Part 3 of 3

So “Matching a treatment choice based on the rate at which smokers metabolize nicotine could be a viable strategy to help guide choices for smokers and in the end improve quit rates”. Anti-smoking experts agreed. “If clinicians can predict which cessation medications will work better for a particular smoker – the slow nicotine metabolizer or the usual metabolizer – the frustrating process of trial and error may be reduced or eliminated,” said Patricia Folan, director of the Center for Tobacco Control at North Shore-LIJ Health System in Great Neck, NY “Quitting is challenging for most tobacco users”.

“Guiding them to proper treatment more quickly and efficiently will provide a more satisfying experience, with possibly less relapse”. Dr Len Horovitz is a pulmonary artist at Lenox Hill Hospital in New York City. He said that, in the future, “a specific therapy may be tailored to the patient based on how the patient metabolizes nicotine chodai. This eliminates the ‘one-size-fits-all’ approach”.

Parts: 1 2 3

Years Of Attempts To Quit Smoking. Part 2 of 3

Years Of Attempts To Quit Smoking – Part 2 of 3

This compared with just 22 percent who had been given a nicotine patch. Among the slow-metabolizing group, both treatments worked equally well at dollop smokers quit, the researchers noted. However, compared with those treated with the nicotine patch, deliberate metabolizers treated with Chantix experienced more side effects. This led the team to conclude that slow metabolizers would fare better – and likely remain cigarette-free – when using the patch.


The exploration was led by Caryn Lerman, a professor of psychiatry and director of the Center for Interdisciplinary Research on Nicotine Addiction at the University of Pennsylvania School of Medicine. She believes that the findings show that not all smokers are alike, and measuring each smokers’ “nicotine metabolite ratio” might someday be a of use tool “to guide treatment choices. This is a much-needed, genetically informed measurement tool that could be translated into clinical practice,” Lerman said in a university dope release.

Parts: 1 2 3

Years Of Attempts To Quit Smoking. Part 1 of 3

Years Of Attempts To Quit Smoking – Part 1 of 3

Years Of Attempts To Quit Smoking. Quitting smoking is notoriously tough, and some smokers may test different approaches for years before they succeed, if ever. But strange research suggests that someday, a simple test might point smokers toward the quitting strategy that’s best for them. It’s been long theorized that some smokers are genetically predisposed to process and rid the body of nicotine more post-haste than others. And now a new study suggests that slower metabolizers seeking to kick the habit will probably have a better treatment experience with the aid of a nicotine patch than the quit-smoking drug varenicline (Chantix). The verdict is based on the tracking of more than 1200 smokers undergoing smoking-cessation treatment.

Blood tests indicated that more than 660 were relatively slow nicotine metabolizers, while the rest were normal nicotine metabolizers. Over an 11-week trial, participants were prescribed a nicotine patch, Chantix, or a non-medicinal “placebo”. As reported online Jan 11, 2015 in The Lancet Respiratory Medicine, healthy metabolizers fared better using the dull compared with the nicotine patch. Specifically, 40 percent of normal metabolizers who were given the drug option were still not smoking at the end of their treatment, the study found.

Parts: 1 2 3

Results Of Kidney Transplantation In HIV-Infected Patients. Part 3 of 3

Results Of Kidney Transplantation In HIV-Infected Patients – Part 3 of 3

But it turns out that transplantation drugs have the opposite import and often suppress the AIDS virus. This is because HIV revs up the immune system while the drugs turn it down. Norman said he expects that the new findings will encourage more surgeons to perform kidney transplants on HIV patients, who are many times surviving long enough to develop diseases that typically target older people. “There are still a lot of people in the community, including transplant professionals, nephrologists and contagious disease professionals, who still don’t appreciate that many of these patients are good prospects for transplantation. They don’t appreciate how many procedures have been done to date, and how we’re getting overall very good outcomes” product.

Parts: 1 2 3

Results Of Kidney Transplantation In HIV-Infected Patients. Part 2 of 3

Results Of Kidney Transplantation In HIV-Infected Patients – Part 2 of 3

There was one troubling finding: the bodies of HIV patients were more likely to reject the kidneys than the bodies of other transplant patients. It’s likely that surgeons will need to better tailor their procedures to help inhibit organ rejection, said transplant surgeon Dr Dorry Segev. This should happen as surgeons gain more experience with transplants in HIV patients an associate professor of surgery and epidemiology at Johns Hopkins Medical Institutions, who was bold with the study findings.


Overall “treatment of HIV-infected patients undergoing kidney transplantation is clearly not straightforward, and this study has identified some challenges for the transplant community to address”. On the effulgent side, transplant procedures didn’t appear to have much of an impact on the HIV infections in the patients.

In years past transplant surgeons worried about how the AIDS virus would interact with the medications given to remove patients that are designed to dampen the immune system. The concern was that “these patients are now doing well, and you’re going to give them medicine and undo all their benefits”.

Parts: 1 2 3